Have faith Steve. Many times a stock, like a kid, gives you hell before turning around and becoming the apple of your eye. As a for instance, about 18 months ago I started a position in Entremed at $14, bought it up to $16, and then continued buying, buying, and buying all the way down to $6 7/8. Sold all into the news on Monday at an average price of about $60. Made enough to take the wife to dinner. Had some left over, even.
Stay focused on the storyline. One day soon the, well, let's call them "folks," who were buying ENMD at $60 - $80 will be buying CYMI at $100-$120 because the NY Times finally gets around to reporting the data that's been on this thread for a year (as was the case with ENMD). When you close your position into the news that day, the few points you're missing in other issues this quarter will look ridiculously inconsequential.
Regards,
John |